Related Experiment Video
Updated: May 9, 2026

Isolation and Culture of Primary Endothelial Cells from Canine Arteries and Veins
Published on: November 18, 2016
Generalised peripheral oedema associated with amlodipine therapy in two dogs
K E Creevy1, M A Scuderi, A E Ellis
1Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, GA, 30602, USA.
Severe edema in dogs can be a serious adverse drug reaction to amlodipine. Veterinarians should monitor for this potential side effect when prescribing amlodipine to canine patients.
Area of Science:
- Veterinary Pharmacology
- Canine Adverse Drug Reactions
Background:
- Amlodipine is a commonly prescribed calcium channel blocker for cardiovascular conditions in dogs.
- Adverse drug reactions (ADRs) can occur with any medication, necessitating vigilance in veterinary practice.
Observation:
- Two cases of dogs experiencing adverse events potentially linked to amlodipine therapy are presented.
- Case 1: Peripheral edema resolved after amlodipine discontinuation.
- Case 2: Diffuse peripheral edema developed rapidly, leading to euthanasia, despite amlodipine initiation for hypertension.
Findings:
- Diffuse peripheral edema is identified as a potential serious adverse drug event associated with amlodipine in dogs.
- The edema in both cases was severe and required clinical investigation to rule out other causes.
- Rapid onset of edema within 72 hours of amlodipine administration was noted in the second case.
Implications:
- Veterinarians must be aware of the potential for severe, diffuse edema as an ADR to amlodipine in dogs.
- This finding highlights the importance of thorough patient monitoring and risk-benefit assessment for commonly used veterinary drugs.
- Further research into the mechanisms and incidence of amlodipine-induced edema in canines is warranted.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Pulmonary Edema II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Nephrotic Syndrome II : Assessment and Medical Management
